Jan 09,2020

BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2020 earnings conference call on Thursday, February 6, 2020, at 8:00 a.m. (ET).

View Analyst & Ambassador Comments
Go to original news
Jan 10,2020

Virta Health Raises $93 Million to Combat the $400B Type 2 Diabetes Epidemic and Expand Diabetes Reversal to Millions

Virta Health, the first company with a treatment to sustainably reverse type 2 diabetes (T2D) without medications or surgery, today announced that it has raised $93 million in Series C funding to combat the growing prevalence of T2D, bringing the total equity funding to $166 million.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jan 12,2020

Cecelia Health Continues Rapid Growth & Expansion Into Telemedicine

Cecelia Health, a leading technology-enabled chronic disease management company based in New York City, has continually innovated for over a decade to transform lives and health outcomes for patients and drive ROI for health plans, pharma and medical device companies and self-insured employers.

PRODUCT

#telehealth

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 13,2020

Bigfoot Biomedical® Announces Initial $45 Million of a Series C Financing Led by Abbott

Funds to Support Breakthrough Therapy for 6M People Living with Insulin-Requiring Type 1 and Type 2 Diabetes

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jan 14,2020

Pioneering E-health start-up GET.ON starts the new year with the new name and its first round of financing

GET.ON Institut, the digital health start-up for online psychotherapy from Hamburg is moving to Berlin and announces that going forward it will operate under the name HelloBetter.

View Analyst & Ambassador Comments
Go to original news
Jan 14,2020

Oviva scores $21M Series B to bring its digital diabetes treatment to more of Europe

Oviva, the health tech startup that provides a digital solution for Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jan 15,2020

Recalculation of warrants in series TO5

Due to the issuance of new shares in the rights issue announced on November 18, 2019, Brighter AB (publ) ("Brighter") has, in accordance with the terms and conditions of the TO5 Brighter warrants, carried out a recalculation of the TO5 warrants.

View Analyst & Ambassador Comments
Go to original news
Jan 15,2020

Tandem Diabetes Care Announces Commercial Launch of the t:slim X2 Insulin Pump with Control-IQ Technology in the United States

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its commercial launch of the t:slim X2™ insulin pump with Control-IQ™ technology, an advanced hybrid-closed loop feature designed to help increase time in range (70-180 mg/dL)1

PRODUCT

#insulin pump

#closed loop

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 17,2020

Bon Secours Mercy Health and Lirio Announce Partnership and Investment

Bon Secours Mercy Health and Lirio, LLC announced their new strategic partnership at the 38th annual J.P. Morgan Healthcare Conference, initiated by a direct investment from Bon Secours Mercy Health in Lirio’s innovative behavior change AI platform.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Jan 17,2020

Brighter is in discussions to acquire Nectarine Health to optimize AI and IoT care solutions

Brighter is in discussions with Nectarine Health’s board and management to acquire the assets of Nectarine Health.

View Analyst & Ambassador Comments
Go to original news